Apr 28 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2016 Mar 31, 2015 Dec 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 29 mln 2 mln 188 mln
(-8.3 pct) (+55.5 pct)
Operating loss 182 mln loss 304 mln loss 1.27
Recurring loss 185 mln loss 204 mln loss 1.27
Net loss 186 mln loss 204 mln loss 1.28
EPS loss 20.28 yen loss 22.29 yen loss 138.94 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T
((Tokyo Headline News Desk +813 6441 1812))